Analytical and Functional Similarity of the Biosimilar Candidate ABP  654 to Ustekinumab Reference Product
ConclusionsBased on a comprehensive similarity assessment, ABP  654 was found to be similar to ustekinumab RP, notwithstanding minor physicochemical differences that are not expected to have a clinically meaningful effect on safety or efficacy. (Source: Drugs in R&D)
Source: Drugs in R&D - October 13, 2023 Category: Drugs & Pharmacology Source Type: research